Sponsor pipeline

Sir Mortimer B. Davis - Jewish General Hospital clinical trial pipeline

Get alerts when Sir Mortimer B. Davis - Jewish General Hospital's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 2
3
Phase 2/3
3
Phase 3
4
Phase 4
1
Not charted: 15 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials top 25 of 26

NCT IDTitleConditionStatusUpdated
Phase 4
NCT07371728 Effect of Aprepitant on Post-operative Nausea and Vomiting in Otologic Surgery Otologic Disease Not Yet Recruiting 2026-01-28
Phase 3
NCT05257629 Aggressive Smoking Cessation Trial (ASAP) Acute Coronary Syndrome Recruiting 2025-04-29
NCT02303327 Comparative Study of Radiotherapy Treatments to Treat High Risk Prostate Cancer Patients Prostate Cancer Active, Not Recruiting 2026-07-23
NCT01444820 Hypofractionated, Dose Escalation Radiotherapy for High Risk Adenocarcinoma of the… Prostate Cancer Active, Not Recruiting 2024-12-04
NCT04150458 Fluorocholine PET/CT Basket Trial Fluorocholine PET/CT Enrolling by Invitation 2024-04-17
Phase 2/3
NCT03051464 Randomizing Two Radiotherapy Boost Options to Avoid Rectal Cancer Surgery Stage II Rectal Cancer Recruiting 2026-06-30
NCT02685397 Management of Castration-Resistant Prostate Cancer with Oligometastases Castration-resistant Prostate Cancer Patients with Oligometastases Active, Not Recruiting 2024-12-04
NCT03459820 Prostate Cancer Patient Management With 18F-DCFPyL PET/CT Prostate Cancer Enrolling by Invitation 2023-11-27
Phase 2
NCT04070209 Management of Oligoprogressive Castration Resistant Prostate Cancer (PCS X) Metastatic Prostate Cancer Active, Not Recruiting 2026-05-27
NCT07254962 CApecitabine Prior to TUmor Resection in Ent Oncology (CAPTURE) Head Neck Cancer Not Yet Recruiting 2025-11-28
NCT06530524 Pretreatment Botulinum Toxin in Head and Neck Cancer Surgery Head Neck Cancer Not Yet Recruiting 2024-07-31
Not applicable
NCT02333110 GRID Therapy as Palliative Radiation for Patients With Advanced and Symptomatic Tumors Patients With Symptomatic or Bulky Tumors (More Than 8 cm) or With Tumors Resistant to Radiation Recruiting 2026-05-12
NCT07188064 A Study Looking at a New Nerve Surgery to Help Men Regain Erections After Prostate Cancer… Prostate Cancer Recruiting 2026-03-10
NCT06521710 Nerve Grafting Technique to Preserve Erectile Function in Patients Undergoing Robotic… Prostate Cancer Recruiting 2024-09-19
NCT06726304 Increasing Physical Contact Between Prenatally Anxious/Depressed Mothers and Their… Prenatal Anxiety Enrolling by Invitation 2026-04-28
NCT07538687 VR Study Virtual Reality for Patients During Arteriovenous Fistula Surgery End Stage Renal Disease on Dialysis Not Yet Recruiting 2026-04-20
NCT07140588 Pilot Study of a New Nerve Grafting Method During Bladder Cancer Surgery to Help Preserve… Bladder Cancer Requiring Cystectomy Not Yet Recruiting 2025-08-24
NCT06458855 Nerve Grafting Technique to Restore Erectile Function Post Radical Prostatectomy Prostate Cancer Active, Not Recruiting 2025-04-18
Not specified
NCT06888388 Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer… Breast Cancer Surgery Recruiting 2026-08-18
NCT04925154 Tradeoffs in Patient Decision Making About Rectal Cancer Treatment: Benefits Compared to… Patient Preference Recruiting 2026-05-14
NCT05139706 Montreal Immune-Related Adverse Events (MIRAE) Study Cancer Recruiting 2026-02-03
NCT05335174 Hypotension Prediction Index in Postoperative Surgical Patients Surgery Recruiting 2025-05-18
NCT05530096 Telo Genomics Technology to Detect & Profile Multiple Myeloma MRD Multiple Myeloma Recruiting 2025-04-03
NCT02573636 The Predictive Value of Coexisting TMPRSS2-ERG Gene Fusion and PTEN Deletion in Prostate… Prostate Cancer Recruiting 2024-12-04
NCT02355171 Personalize My Treatment (PMT) Registry Cancer Active, Not Recruiting 2026-10-13

Disease areas by active trials, top 10 of 11

Get alerts when Sir Mortimer B. Davis - Jewish General Hospital's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free